Biotech Pipeline

Showing 388 articles
Business

New Gold Shareholders Overwhelmingly Approve Coeur Mining Acquisition, Paving Way for Major North American Precious Metals Player

Shareholders of New Gold Inc. (TSX:NGD) and Coeur Mining, Inc. have given resounding approval to Coeur's plan to acquire all outstanding shares of New Gold. The vote clears a critical path for the merger, which now awaits final regulatory and court nods to create a significantly larger, diversified precious metals producer with enhanced scale and exploration prospects across North America.

Business

MGM Resorts Bets Big on Nevada Solar, But Can Green Power Spark a Stock Revival?

MGM Resorts International is powering its Las Vegas Strip operations with a major new solar and battery storage deal. This strategic shift toward renewables comes as the company's stock shows mixed signals, trading below some fair value estimates yet at a high earnings multiple, leaving investors to weigh long-term sustainability against immediate financial metrics.

Business

Ondas Secures Coveted Pentagon 'Blue List' Approval for Optimus Drone, Fueling Investor Debate on Valuation

Ondas Holdings' flagship Optimus drone system has received the Defense Contract Management Agency's critical 'Blue List' certification, clearing it for broader U.S. defense and national security deployment. The milestone has ignited a surge in the company's stock while prompting analysts to scrutinize its long-term path to converting regulatory approval into sustainable revenue.

Business

Aeris Resources Surges on Strong Production, Debt Clearance; But Is the Rally Overextended?

Aeris Resources (ASX:AIS) shares have soared following a robust December quarter report featuring record copper-equivalent output and full repayment of a A$50 million debt facility. The operational momentum has fueled a dramatic 350% one-year shareholder return, yet analysts are divided on whether the stock's current price accurately reflects its underlying value or has overshot fundamentals.